Ensol Biosciences Inc. (XKON:A140610) announced a private placement of round 1 non-guaranteed private convertible bonds with bearer interest for gross proceeds of KRW 3,000,000,000 with Tiger Asset Management Discretionary Investment Co., Ltd. on February 5, 2021. The bonds are redeemable at par, does not bear any interest and matures on February 16, 2026. The bonds are fully convertible into 164,835 shares representing 1.82% stake at a fixed conversion price of KRW 18,200 per share between February 16, 2022 and January 16, 2026. The subscription date is February 15, 2021 and payment date is February 16, 2021. The bonds are subject to 1 year restriction. The transaction is approved by the board of directors of the company.